---
title: "Berkshire's UnitedHealth Bet Highlights Long-Term Confidence Despite Depressed Earnings"
description: "Warren Buffett's Berkshire Hathaway and investor Michael Burry have recently invested in UnitedHealth Group Inc., signaling confidence in the company's long-term prospects despite current depressed ea"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/253507988.md"
published_at: "2025-08-18T17:35:27.000Z"
---

# Berkshire's UnitedHealth Bet Highlights Long-Term Confidence Despite Depressed Earnings

> Warren Buffett's Berkshire Hathaway and investor Michael Burry have recently invested in UnitedHealth Group Inc., signaling confidence in the company's long-term prospects despite current depressed earnings. BofA Securities remains optimistic, projecting earnings recovery by 2027, with a price forecast increase from $290 to $325. The upcoming 2027 Medicare Advantage rate update is crucial for profitability, as recent performance and ratings will significantly impact margins. UnitedHealth's stock rose 3.58% to $314.88, reflecting positive market sentiment.

On Friday, high-profile investors **Michael Burry** and **Warren Buffett** took positions in **UnitedHealth Group Inc.** UNH. Warren Buffett's fund bought little more than 5 million shares, and Burry disclosed in 13F filings that he purchased call contracts against 350,000 shares of UnitedHealth.

The holdings suggest Burry is betting on a sector turnaround, particularly as Medicare Advantage rates have exceeded expectations for 2026, and UnitedHealth's competitive positioning remains strong despite recent setbacks.

Berkshire Hathaway's stake in UnitedHealth signals confidence but largely reinforces the consensus that earnings are currently depressed. Investors with a five-year horizon could benefit, though most still expect steady annual returns.

***Also Read: UnitedHealth: Burry, Buffett, Tepper Go Long As Halvorsen Exits***

**Bank of America Securities** (BofA) remains bullish, projecting earnings recovery by 2027, which could drive both upside in profits and valuation multiples.

Analyst Kevin Fischbeck raised the price forecast from $290 to $325 on the better peer multiples, reaffirming the Neutral rating.

For UnitedHealth, guidance is everything. The stock only works if the company delivers, particularly with upside on its medical loss ratio.

BofA notes it's been over two years since a "United-type" quarter, but steady beats and raises could restore confidence in management and its grasp of healthcare trends.

CMS will release 2027 Star Ratings in mid-October, determining how much UnitedHealth's Medicare Advantage business qualifies for the 5% quality bonus. With Medicare Advantage margins thin at 3–5%, ratings are a key driver of profitability.

Recent drops at **Humana Inc.** HUM and **CVS Health Group Inc.** CVS underscore the risk.

If UnitedHealth posts weaker scores, margin recovery could be pushed back to 2028, leaving it no better than peers.

For UnitedHealth, the key focus is the 2027 Medicare Advantage (MA) rate update, due in February 2026. The 2026 update delivered the most significant increase in a decade, easing concerns about an unfriendly policy stance.

The bigger risk lies in coding changes. With 2026 as the final year of the V28 phase-in, no extra cuts were applied, which improved sentiment. However, 2027 could pair a stronger rate update with a new coding adjustment (V29), potentially offsetting gains.

**Price Action:** UNH stock is trading higher by 3.58% to $314.88 at last check Monday.

-   ***Opendoor (OPEN) Hits Golden Cross: Meme-Stock Mania Meets Technical Bull Signal***

*Photo by Poetra.RH via Shutterstock*

### Related Stocks

- [BRK.A.US - Berkshire Hathaway](https://longbridge.com/en/quote/BRK.A.US.md)
- [UNH.US - Unitedhealth](https://longbridge.com/en/quote/UNH.US.md)
- [BRK.B.US - Berkshire Hathaway B](https://longbridge.com/en/quote/BRK.B.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 段永平试水 “AI 交易”：卖苹果加仓英伟达，“新入” CoreWeave、Credo 和 Tempus | CoreWeave 专门搭建高性能 GPU 集群，把算力租给 AI 公司和企业客户；如果说 GPU 是心脏，Credo 提供的高速互联芯片和光模块就是血管，跟 AI 服务器迭代高度绑定；Tempus 则致力于将 AI 应用于精准医疗，尤其是 | [Link](https://longbridge.com/en/news/276189117.md) |
| 伯克希尔哈撒韦在第四季度购入了纽约时报的股票。你是否也应该将纽约时报纳入你的投资组合中呢？ | 伯克希尔哈撒韦在第四季度购买了纽约时报的股票。你也应该将 NYT 加入你的投资组合吗？ | [Link](https://longbridge.com/en/news/276265837.md) |
| DELL, SPOT, UNH：全球最大的对冲基金正在市场中寻找抄底机会 | 桥水基金（Bridgewater Associates），全球最大的对冲基金，管理资产达 1360 亿美元，在 2025 年第四季度对表现不佳的股票进行了重大投资，包括戴尔（DELL）、Spotify（SPOT）和联合健康（UnitedHe | [Link](https://longbridge.com/en/news/276384705.md) |
| 沃伦·巴菲特的收益曾是市场的两倍——直到监管改变了游戏规则 | Chamath Palihapitiya 讨论了监管变化，特别是 2000 年的公平披露条例（Reg FD），如何影响沃伦·巴菲特的投资表现。在 Reg FD 之前，由于信息不对称，巴菲特的回报是市场的两倍。该法规禁止选择性披露后，巴菲特的 | [Link](https://longbridge.com/en/news/276003396.md) |
| Liberty Media Corporation - Liberty Live Series C（纳斯达克代码：LLYVK）的主要股东伯克希尔哈撒韦公司出售了 59,411 股 | 伯克希尔哈撒韦公司（Berkshire Hathaway Inc.），作为自由媒体公司（Liberty Media Corporation）- 自由直播 C 系列（Liberty Live Series C，NASDAQ:LLYVK）的主要 | [Link](https://longbridge.com/en/news/276179913.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.